Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 1/20 | 0.68 |
| ▸ | CA9 | Q16790 | 1/20 | 0.68 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.58 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.58 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.58 |
| ▸ | MAPT | P10636 | 2/20 | 0.58 |
| ▸ | RAB9A | P51151 | 1/20 | 0.58 |
| ▸ | MEN1 | O00255 | 3/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.56 |
| ▸ | GSK3B | P49841 | 1/20 | 0.54 |
| ▸ | POLB | P06746 | 2/20 | 0.51 |
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.50 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.50 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.50 |
| ▸ | NPC1 | O15118 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30097999 | 0.83 | KDM4E (0.73) | ALDH1A1NPSR1KDM4EMAPTMEN1 | |
| SCHEMBL8940040 | 0.83 | CA12 (0.73) | CA12CA9ALDH1A1NPSR1KDM4E | |
| SCHEMBL30632370 | 0.82 | CA12 (0.47) | CA12CA9ALDH1A1NPSR1KDM4E | |
| SCHEMBL11148327 | 0.81 | CA12 (0.70) | CA12CA9ALDH1A1NPSR1KDM4E | |
| SCHEMBL29744481 | 0.81 | CA12 (1.00) | CA12CA9ALDH1A1NPSR1KDM4E | |
| SCHEMBL522649 | 0.81 | CA12 (1.00) | CA12CA9ALDH1A1NPSR1KDM4E | |
| SCHEMBL11571278 | 0.81 | KDM4E (0.59) | CA12CA9ALDH1A1NPSR1KDM4E | |
| SCHEMBL7437619 | 0.80 | CA12 (0.63) | CA12CA9ALDH1A1NPSR1KDM4E | |
| SCHEMBL29642483 | 0.80 | ALDH1A1 (0.57) | CA12CA9ALDH1A1KDM4EMEN1 | |
| SCHEMBL3756580 | 0.80 | ALDH1A1 (0.57) | CA12CA9ALDH1A1KDM4EMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 397 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114181133-B | Preparation method of glycine derivative acetamide compound | 上海应用技术大学 | 2023-04-28 | — | — | CN | claimed |
| CN-114181133-A | Preparation method of glycine derived acetamide compound | 上海应用技术大学 | 2022-03-15 | — | — | CN | claimed |
| US-20110039682-A1 | METHOD FOR SYNTHESIZING ONE-DIMENSIONAL HELICAL NANOPOROUS STRUCTURES AND METHOD FOR SYNTHESIZING GLYCINE-DERIVED SURFACTANT FOR SYNTHESIZING HELICAL NANOPOROUS STRUCTURES | THERMOLON KOREA CO., LTD. (KR) | 2011-02-17 | — | — | US | claimed |
| WO-2009131324-A2 | METHOD FOR SYNTHESIZING ONE-DIMENSIONAL HELICAL NANOPOROUS STRUCTURES AND METHOD FOR SYNTHESIZING GLYCINE-DERIVED SURFACTANT FOR SYNTHESIZING HELICAL NANOPOROUS STRUCTURES | THERMOLON KOREA CO.,LTD. (KR) | 2009-10-29 | — | — | WO | claimed |
| US-3957761-A | Process for the production of 1-aminomethyl-6-phenyl-4h-s-triazolo-[4,3-a][1]benzodiazepines and intermediates | THE UPJOHN COMPANY (US) | 1976-05-18 | — | — | US | claimed |
| EP-4073062-B1 | FUNCTIONALIZED HETEROCYCLIC COMPOUNDS AS MODULATORS OF STIMULATOR OF INTERFERON GENES (STING) | RYVU THERAPEUTICS S A (PL) | 2026-04-29 | — | — | EP | disclosed |
| US-12564583-B2 | Small molecules against cereblon to enhance effector T cell function | Lee Moffitt Cancer Center and Research Institute, Inc. (US) | 2026-03-03 | — | — | US | disclosed |
| US-12435080-B2 | sGC stimulators | TISENTO THERAPEUTICS INC. (US) | 2025-10-07 | — | — | US | disclosed |
| EP-3749306-B1 | NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE INHIBITORS AND METHODS FOR USE OF THE SAME | UNIV INDIANA TRUSTEES (US) | 2025-09-03 | — | — | EP | disclosed |
| US-20250243177-A1 | sGC STIMULATORS | CYCLERION THERAPEUTICS, INC. | 2025-07-31 | — | — | US | disclosed |
| EP-3924349-B1 | AMINO ACID DERIVATIVES FOR THE TREATMENT OF INFLAMMATORY DISEASES | THE ROSKAMP INST (US) | 2025-06-25 | — | — | EP | disclosed |
| CN-119838022-A | Amatoxin conjugates containing branched linkers | 杭州多禧生物科技有限公司 | 2025-04-18 | — | — | CN | disclosed |
| US-4141901-A | REDUCING AN AZIDO DERIVATIVE | SHIONOGI & CO., LTD. (JP) | 1979-02-27 | — | — | US | disclosed |
| US-4140688-A | Tricyclic (azeto-isoquinoline) β-lactams | SMITHKLINE CORPORATION (US) | 1979-02-20 | — | — | US | disclosed |
| US-4122262-A | ANTIBACTERIAL | SMITHKLINE CORPORATION (US) | 1978-10-24 | — | — | US | disclosed |
| US-4118742-A | VIRICIDES | ELI LILLY AND COMPANY (US) | 1978-10-03 | — | — | US | disclosed |
| US-4089956-A | 7-Acylamino-8-oxo-3-oxa-1-azabicyclo[4.2.0]octane-2-carboxylic acid derivatives and bactericidal compositions and use thereof | SMITHKLINE CORPORATION (US) | 1978-05-16 | — | — | US | disclosed |
| US-4085100-A | Intermediate for dephthaloylation of azetidinone compounds | SMITHKLINE CORPORATION (US) | 1978-04-18 | — | — | US | disclosed |
| US-3957761-A | Process for the production of 1-aminomethyl-6-phenyl-4h-s-triazolo-[4,3-a][1]benzodiazepines and intermediates | THE UPJOHN COMPANY (US) | 1976-05-18 | — | — | US | disclosed |
| US-3943123-A | ANTIBIOTIC | KONINKLIJKE NEDERLANDSCHE GIST-EN SPIRITUSFABRIEK N.V. (NL) | 1976-03-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12435080-B2 | sGC stimulators | GUCY1A2, PRKG1, PDE2A | CA12 4557/4885CA9 3306/4885ALDH1A1 2355/4885 |
| US-12564583-B2 | Small molecules against cereblon to enhance effector T cell function | CRBN, CD4, ICOS | CA12 3365/4885CA9 2216/4885ALDH1A1 2373/4885 |
| US-20250243177-A1 | sGC STIMULATORS | GUCY1A1, PTGIS, GUCY1B1 | CA12 4537/4885CA9 3829/4885ALDH1A1 1325/4885 |
| US-20110039682-A1 | METHOD FOR SYNTHESIZING ONE-DIMENSIONAL HELICAL NANOPOROUS STRUCTURES AND METHOD FOR SYNTHESIZING GLYCINE-DERIVED SURFACTANT FOR SYNTHESIZING HELICAL NANOPOROUS STRUCTURES | GGH, STOM, GLRB | CA12 167/4885CA9 678/4885ALDH1A1 4783/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.